Edwards Pradenas

Featured in: Favicon

nature.com Favicon

journalofinfection.com Favicon

biorxiv.org Favicon

onlinelibrary.wiley.com

Articles

Immunization with V987H-stabilized Spike glycoprotein protects K18-hACE2 mice and golden Syrian hamsters upon SARS-CoV-2 infection - Nature Communications

Mar 20, 2024 | nature.com | Marco Brustolin |Nuria Pedreno-Lopez |Jordi Rodon |Víctor Urrea |Edwards Pradenas |Anna Pons-Grífols | +10 more

AbstractSafe and effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines are crucial to fight against the coronavirus disease 2019 pandemic. Most vaccines are based on a mutated version of the Spike glycoprotein [K986P/V987P (S-2P)] with improved stability, yield and immunogenicity. However, S-2P is still produced at low levels.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →